Azimut Holding SpA
DUS:HDB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Azimut Holding SpA
DUS:HDB
|
IT |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
U
|
Unum Group
F:UUM
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
Valeo SE
F:VSA2
|
FR |
|
dentalcorp Holdings Ltd
F:6A7
|
CA |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
S
|
SoftBank Group Corp
DUS:SFT
|
JP |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
Wall St Price Targets
HDB Price Targets Summary
Azimut Holding SpA
According to Wall Street analysts, the average 1-year price target for HDB is 38.78 EUR with a low forecast of 35.12 EUR and a high forecast of 44.86 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HDB's stock price target?
Price Target
38.78
EUR
According to Wall Street analysts, the average 1-year price target for HDB is 38.78 EUR with a low forecast of 35.12 EUR and a high forecast of 44.86 EUR.
What is the Revenue forecast for Azimut Holding SpA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Azimut Holding SpA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 4 years is 8%.
What is the Net Income forecast for Azimut Holding SpA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 4 years is 7%.
